Loading paragraph...
Today's Most Actively Traded Stocks
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| TQQQ | ProShares Trust - ProShares UltraPro Qqq | $50.47 | -$2.05 | -3.91% | 22.6M | - | $17.50$60.69 |
| TSLL | Direxion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares | $16.02 | -$0.38 | -2.31% | 19.2M | - | $6.29$24.49 |
| ONDS | Ondas | $10.36 | -$1.03 | -9.01% | 16.9M | $4.8B | $0.57$15.28 |
| AMDL | GraniteShares ETF Trust - GraniteShares 2x Long Amd Daily ETF | $13.56 | -$5.74 | -29.74% | 15.8M | - | $2.77$25.86 |
| BSX | Boston Scientific | $75.48 | -$16.14 | -17.62% | 14.5M | $136B | $75.32$109.50 |
| SQQQ | ProShares Trust - ProShares UltraPro Short Qqq | $70.63 | $2.67 | 3.93% | 13.8M | - | $61.72$289.00 |
| QQQ | Invesco QQQ Trust | $608.84 | -$7.68 | -1.25% | 10.8M | - | $402.39$637.01 |
| PFE | Pfizer | $26.40 | $0.63 | 2.42% | 10.7M | $147B | $20.92$27.69 |
| IBIT | iShares Bitcoin Trust | $42.32 | -$0.98 | -2.26% | 1.9M | - | $41.30$71.82 |
| SAN | Banco Santander | $12.64 | $0.41 | 3.31% | 1.9M | $179B | $5.51$13.11 |
| SMCI | Super Micro Computer | $33.63 | $3.96 | 13.35% | 1.8M | $18B | $27.60$66.44 |
| CFLT | Confluent | $30.36 | -$0.09 | -0.30% | 1.8M | $11B | $15.64$37.90 |
| ETHA | iShares Ethereum Trust - iShares Ethereum Trust ETF | $16.39 | -$0.95 | -5.48% | 1.6M | - | $10.99$36.80 |
| AAPL | Apple | $274.84 | $5.36 | 1.99% | 1.5M | $4.0T | $169.21$288.62 |
| AMD | Advanced Micro Devices | $208.64 | -$33.47 | -13.82% | 1.4M | $394B | $76.48$267.08 |
| UBER | Uber Technologies | $73.48 | -$4.45 | -5.71% | 1.2M | $162B | $60.63$101.99 |
| NVDA | Nvidia | $177.51 | -$2.83 | -1.57% | 1.2M | $4.4T | $86.62$212.19 |
| INTC | Intel | $48.91 | -$0.34 | -0.69% | 1.1M | $246B | $17.67$54.60 |
| PYPL | PayPal | $41.35 | -$0.35 | -0.84% | 1.1M | $39B | $39.96$79.74 |
| PLTR | Palantir Technologies | $141.77 | -$16.11 | -10.20% | 1M | $376B | $66.12$207.52 |
| NVO | Novo Nordisk | $47.24 | -$3.06 | -6.08% | 833.2K | $169B | $43.08$93.80 |
| ENPH | Enphase Energy | $51.85 | $14.57 | 39.08% | 826.6K | $4.9B | $25.78$70.78 |
| SOFI | SoFi Technologies | $21.01 | -$0.76 | -3.47% | 814.7K | $27B | $8.60$32.73 |
| IREN | Iren | $47.86 | -$6.53 | -12.01% | 700.2K | $18B | $5.13$76.87 |
| HOOD | Robinhood Markets | $80.64 | -$6.43 | -7.38% | 638.4K | $78B | $29.66$153.86 |
| USAR | USA Rare Earth | $23.36 | -$2.61 | -10.05% | 415.4K | $3.8B | $5.56$43.98 |
Related Articles
Featured Article
2 Growth Stocks to Hold for the Next Decade
Prosper Junior Bakiny|Feb 4, 2026
Both had strong momentum last year.
Is Nvidia Stock a Buy?
Robert Izquierdo|Feb 4, 2026
The semiconductor giant plays a central role in the expansion of the AI market.
Better Growth Stock: Nu Holdings vs. SoFi Technologies
Neil Patel|Feb 4, 2026
Shares in these two innovative banking entities have soared in the past 36 months.
Better Artificial Intelligence Stock: Nvidia vs. Palantir
Stefon Walters|Feb 4, 2026
Valuation is one of the key differentiators between these two AI investment options.
The Financial Stock Big Money Managers Are Quietly Buying
Thomas Niel|Feb 4, 2026
As the popular fintech stock trades sideways, institutional investors are increasing their positions.
Will the Market Crash in 2026? Here's What History Says and What to Do About It
Prosper Junior Bakiny|Feb 3, 2026
Always be prepared.
Why 2026 Could Be the Year Pfizer's Stock Finally Takes Off
David Jagielski, CPA|Feb 3, 2026
The company expects to launch more than 20 pivotal late-stage trials this year.
Nvidia Stock Investors Got Great News From Palantir and Teradyne
Beth McKenna|Feb 3, 2026
Nvidia reports its quarterly results on Feb. 25, and all signs so far are pointing to a great quarter.
Will Apple's Explosive Growth Continue? This Often Overlooked Figure Answers the Question.
Adria Cimino|Feb 3, 2026
In spite of Apple's earnings strength, its stock underperformed the S&P 500 last year.
Should You Buy Intel Stock After Its Post-Earnings Dip?
David Jagielski, CPA|Feb 3, 2026
The company beat expectations, but its guidance was underwhelming.
